Norgestimate And Ethinyl Estradiol
Product Images NDC 68788-7894

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 68788-7894). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister-label (Blister Label)

Norgestimate and Ethinyl Estradiol Tablets USP packaging label showing a 28-tablet oral contraceptive blister pack with dosage strengths of 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, and 0.25 mg/0.035 mg. The label includes a dosing calendar organized by weeks and days (Sunday through Saturday), manufacturer and labeler information for Preferred Pharmaceuticals Inc and Glenmark Pharmaceuticals, storage instructions, and a barcode.*

FDA Label Image

Trinessa (norgestimate And Ethinyl Estradiol Tablets (Carton Label)

The packaging label for TriNessa (norgestimate and ethinyl estradiol tablets) from Preferred Pharmaceuticals Inc shows it as a generic for Ortho Tri-Cyclen 28 Day. The label includes storage instructions, cautions, barcode, and bilingual usage directions. Manufacturer listed is Glenmark Pharmaceuticals Inc., USA. Specific dosage strength, package size, and expiration dates are not visible in the image.*

FDA Label Image

Structures (Chem Structures)

Chemical structure diagrams of Norgestimate and Ethinyl Estradiol, USP. The image shows the molecular structures with labeled chemical groups for each active ingredient in the product Norgestimate and Ethinyl Estradiol by Preferred Pharmaceuticals Inc.*

FDA Label Image

Fig-c (Fig C)

An instructional illustration labeled Figure C showing how to peel back adhesive packaging. It depicts a hand lifting a flap, with directional arrows pointing to "Start" and "Week 2," and days of the week "SUN" and "MON" displayed above two circular pill compartments.*

FDA Label Image

Fig-d (Fig D)

An instructional illustration showing how to use two different Norgestimate and Ethinyl Estradiol tablets blister packs. Each pack is organized in a 4-week layout with days of the week labeled. A hand is shown peeling back the foil covering a tablet. One pack label displays strengths 0.25 mg/0.035 mg, and the other shows multiple strengths: 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, and 0.25 mg/0.035 mg. Both include a caution about child safety.*

FDA Label Image

Fig-e (Fig E)

An instructional illustration showing a finger pointing to pill calendar days labeled Tuesday and Wednesday, marking the start and week 2 for taking medication, related to Norgestimate and Ethinyl Estradiol use.*

FDA Label Image

Fig-f (Fig F)

An instructional diagram showing a weekly pill calendar for Sunday and Monday over four weeks. It includes arrows indicating the start of each week and a hand pressing on the Sunday pill of Week 4. The diagram is intended to guide proper pill intake scheduling.*

FDA Label Image

Img1-1 (Img1 1)

An illustrated monthly medication schedule for Norgestimate and Ethinyl Estradiol tablets 0.25 mg/0.035 mg. The diagram shows a 28-day cycle divided into four weeks, with circles representing daily pills. Arrows indicate the start of each week. Blue pills are labeled as active doses for weeks 1 to 3, and light green pills are labeled inactive for week 4. A note at the bottom advises keeping medication out of reach of children.*

FDA Label Image

Img1 (Img1)

An illustrated 28-day pill calendar for Norgestimate and Ethinyl Estradiol Tablets USP 0.25 mg/0.035 mg. The diagram marks four weeks, each with seven pill slots representing days of the week. It labels blue pills as active and light green pills as inactive, with arrows indicating the start of weeks 1, 2, and 4.*

FDA Label Image

Img2-1 (Img2 1)

A dosing guide for Norgestimate and Ethinyl Estradiol Tablets USP, showing a 4-week schedule with pills color-coded by week: white to off-white, light blue, and blue pills are active, and light green pills are inactive. Days of the week and start direction are indicated. Includes a child safety warning.*

FDA Label Image

Img2 (Img2)

An illustrated pill chart for Norgestimate and Ethinyl Estradiol tablets showing a 4-week cycle with daily circular compartments labeled by week and day (Sunday to Saturday). It distinguishes four pill colors: white to off-white, light blue, and blue pills (all active), and light green pills (inactive). A note indicates the package is not child resistant.*

FDA Label Image

Img3 (Img3)

A vertical chart illustrating pregnancy rates per 100 women in one year associated with various birth control methods. The chart shows fewer pregnancies at the top with methods like implants, injections, intrauterine devices, and sterilization; followed by birth control pills, skin patch, and vaginal ring with hormones. Moderate pregnancies correspond to condoms and diaphragm, then no sex during fertile days, spermicide, and withdrawal. Most pregnancies occur with no birth control at the bottom.*

FDA Label Image

Logo-1 (Logo 1)

FDA Label Image

Logo (Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.